The Veterinary Intravenous (IV) Solutions Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
What are the Historical Growth Trends in the Veterinary Intravenous (IV) Solutions Market?
The market size of the veterinary intravenous (IV) solutions has experienced robust growth in the past few years. The market is projected to increase from $1.5 billion in 2024 to $1.62 billion in 2025, with a compound annual growth rate (CAGR) of 8.1%.
What are the 2025 Market Projections: Forecasted Size & Growth Rate for the Veterinary Intravenous (IV) Solutions Industry?
By 2029, the veterinary intravenous (IV) solutions market is forecasted to grow to $2.19 billion, with a compound annual growth rate (CAGR) of 7.8%.
Download Your Free Sample of the 2025 Veterinary Intravenous (IV) Solutions Market Report and Uncover Key Trends Now!
What are the Key Growth Drivers Fueling the Veterinary Intravenous (IV) Solutions Market?
The key drivers in the veterinary intravenous (iv) solutions market are:
• Increasing adoption of pet insurance
• Rising animal healthcare expenditure
• Growing awareness of animal healthcare
• Rising incidence of animal diseases
Global Market Segmentation: Identifying Major Veterinary Intravenous (IV) Solutions Industry Segments
The veterinary intravenous (IV) solutions market covered in this report is segmented –
1) By Product: Isotonic Crystalloids, Dextrose Solutions, Synthetic Colloids, Natural Colloids, Parenteral Nutrition
2) By Animal Type: Companion Animals, Production Animals
3) By End-User: Veterinary Hospitals And Clinics, Research Institutes, Other End-Users
Subsegments:
1) Isotonic Crystalloids: Normal Saline (0.9% NaCl), Lactated Ringer's Solution, Dextrose in Water (D5W), Ringer's Solution, Balanced Electrolyte Solutions
2) Dextrose Solutions: Dextrose 5% in Water (D5W), Dextrose 10% in Water (D10W), Dextrose 20% in Water (D20W), Dextrose 50% in Water (D50W)
3) Synthetic Colloids: Hydroxyethyl Starch (HES), Dextran, Gelatins
4) Natural Colloids: Albumin, Fresh Frozen Plasma (FFP), Blood Products
5) Parenteral Nutrition: Total Parenteral Nutrition (TPN) Solutions, Partial Parenteral Nutrition Solutions, Lipid Emulsions, Amino Acid Solutions
Pre-order the 2025 Veterinary Intravenous (IV) Solutions Global Market Report for Fast Delivery & Comprehensive Insights!
What are the emerging Trends Shaping the Future of the Veterinary Intravenous (IV) Solutions Market?
The key trends in the veterinary intravenous (iv) solutions market are:
• Technological advancements are shaping the future of the veterinary intravenous solutions market.
• The development of diverse product formulations is a significant emerging trend.
• The integration of telemedicine into veterinary IV solutions is a growing practice.
• Smart veterinary intravenous systems are becoming increasingly prevalent in the market.
Who Are the Top Competitors & Leading Players in the Veterinary Intravenous (IV) Solutions Market?
Major players in the veterinary intravenous (iv) solutions market are:
• Merck & Co. Inc.
• Baxter International Inc.
• Zoetis Inc.
• Fresenius Kabi AG
• Elanco Animal Health Incorporated
• B. Braun Melsungen AG
• Virbac SA
• Dechra Pharmaceuticals PLC
• Vetoquinol SA
• Norbrook Laboratories Limited
• Ceva Santé Animale
• Revival Animal Health Inc.
• Aromor Animal Health
• Jorgensen Laboratories LLC
• Pharmacosmos AS
• Sykes Veterinary International Pty Ltd.
• Rusoma Laboratories Private Limited
• Patterson Companies Inc.
• NexGen Veterinary
• Soxa Formulations & Research Pvt. Ltd
Regional Dominance: Which Area Leads the Global Template Market?
North America was the largest region in the veterinary intravenous (IV) solutions market in 2024
